Join the Estradiol group to help and get support from people like you.
Estradiol News
Related terms: Estradiol Topical
Type Of Hormone Therapy Can Alter Breast Cancer Risk, Study Says
MONDAY, July 7, 2025 — Some women have expressed concerns about the risk of breast cancer associated with using hormone therapy to treat symptoms of menopause like hot flashes and night sweats, and no...
Hormone Therapy Tied to Worse Bladder Health in Postmenopausal Women
TUESDAY, May 6, 2025 – Hormone therapy use is linked to worse bladder health in postmenopausal women, according to a study published online April 29 in Menopause. Camille P. Vaughan, M.D., from the ...
Common Photosensitizing Drugs Increase Skin Cancer Risk
TUESDAY, April 1, 2025 – Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in Photodermatology, Photoimmunology & ...
Certain Birth Control Pills, Devices Linked to Higher Heart Risks
THURSDAY, Feb. 13, 2025 – The most common formulation of birth control pills has been linked to a doubling of relative risk of heart attack and stroke, a new study finds. Contraceptive vaginal rings...
Estrogen May Trigger Binge Drinking, Prelim Study Suggests
TUESDAY, Dec. 31, 2024 – A woman’s binge drinking might be related to her hormones. The female hormone estrogen appears to promote binge drinking in women, a new mouse study published recently in t...
Some HRT Pills May Pose Special Risk for Blood Clots
THURSDAY, Nov. 28, 2024 – Certain hormone replacement therapy pills appear to increase the risk of heart disease and serious blood clots in women going through menopause, a new study says....
Short-Term Hormone Therapy for Menopause Won't Harm Women's Brains
FRIDAY, Nov. 22, 2024 – Four years of hormone replacement therapy to help women deal with menopausal symptoms causes no harm to the brain, even over the long term, new research shows. "In the...
Hormone Tx Tied to Reductions in Insulin Resistance
WEDNESDAY, Sept. 11, 2024 – Hormone therapy (HT) is associated with significantly reduced insulin resistance in healthy postmenopausal women, according to a study presented at the annual meeting of...
Many Women Continue Using Menopausal Hormone Therapy Beyond Age 65 Years
WEDNESDAY, Sept. 11, 2024 – Many women older than 65 years have validated menopausal symptoms severely affecting their quality of life and continue to use menopausal hormone therapy (MHT), according...
TherapeuticsMD Announces FDA Approval of Imvexxy (estradiol vaginal inserts) for the Treatment of Dyspareunia Due to Menopause
BOCA RATON, Fla., May 30, 2018 /PRNewswire/ – TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women's healthcare company, today announced that the United States Food and Drug Administration (FDA)...
Noven Receives FDA Approval of a New Indication with a New Dose for Minivelle
Miami, FL and New York, NY, – September 24, 2014 – Noven Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved a new indication with a new dose of...
FDA Medwatch Alert: Olympia Pharmacy Sterile Compounded Products: Recall - Concerns About Sterility Assurance
[Posted 05/30/2013] ISSUE: Lowlite Investments d/b/a Olympia Pharmacy ("Lowlite") notified the public of a voluntary multi-state recall of all sterile drug products compounded by the pharmacy that ...
FDA Approves 10 mcg Dose of Vagifem for the Treatment of Atrophic Vaginitis Due to Menopause
PRINCETON, N.J., Dec. 2 /PRNewswire-FirstCall/ – Novo Nordisk said today that the U.S. Food and Drug Administration (FDA) has approved a 10 mcg dose formulation of Vagifem (estradiol vaginal...
Further information
Related condition support groups
Atrophic Vaginitis, Postmenopausal Symptoms, Overactive Bladder, Prostate Cancer